'Sunshine Act' Gets Guarded Reaction

Professional associations and lobbying groups have so far avoided bashing the final rule, which details how financial relationships between drug and device manufacturers and healthcare providers must be disclosed to the federal government.

Name:
E-mail:
Website:
Please enter your comment below:

Please enter the text below: